Patent 12185177

Extensions

Patent term adjustments, term extensions, continuations, divisionals, family members, and expiration dates.

Active provider: Google · gemini-2.5-flash

Extensions

Patent term adjustments, term extensions, continuations, divisionals, family members, and expiration dates.

✓ Generated

For US patent 12185177, here's a detailed breakdown of its term and related applications:

Patent Term Adjustments (PTA) and Patent Term Extensions (PTE):

  • Patent Term Adjustment (PTA): PTA is granted to compensate patent applicants for delays incurred during prosecution before the United States Patent and Trademark Office (USPTO). Any PTA would add to the standard 20-year lifespan of the issued patent. Without direct access to the USPTO's Patent Center or official patent record for US12185177, the specific PTA granted (if any) cannot be determined from the provided information. The USPTO does not calculate expiration dates for patents but provides a calculator as a resource to help estimate.
  • Patent Term Extension (PTE): PTE is awarded to compensate for delays in obtaining regulatory approval for certain patented products, such as pharmaceuticals. There is no information in the provided patent text to suggest that US12185177 is eligible for or has received any Patent Term Extension.

Continuation Applications, Divisional Applications, and Related Family Members:

US Patent 12185177B2 is part of a patent family and claims priority from earlier applications. This means it is a continuation or continuation-in-part of previous applications.

  • Priority Claim: The patent explicitly states it is a continuation of U.S. patent application Ser. No. 16/570,298, filed September 13, 2019. This application, in turn, is a continuation of U.S. patent application Ser. No. 15/346,599, filed November 8, 2016 (now U.S. Pat. No. 10,469,980). This application is also a continuation of U.S. patent application Ser. No. 13/987,520, filed August 3, 2013 (now U.S. Pat. No. 9,532,164). Finally, the earliest application in the chain for which a benefit is claimed is U.S. patent application Ser. No. 11/974,258, filed on October 12, 2007. The disclosures of these parent applications are incorporated by reference.

  • Related Family Members (Applications Claiming Priority):

    • US11/974,258 (filed 2007-10-12, published as US20090100342A1) - "Method and system for presenting address and mapping information"
    • US13/987,520 (filed 2013-08-03, granted as US9532164B2) - "Mashing mapping content displayed on mobile devices"
    • US15/346,599 (filed 2016-11-08, granted as US10469980B2) - "Mashing mapping content displayed on mobile devices"
    • US16/570,298 (filed 2019-09-13) - The direct parent application to the current patent. (The patent text provided does not state if this application resulted in a granted patent before US12185177B2, but it is explicitly listed as a continuation).
  • Other Versions/Priority Applications of US12185177B2:

    • US18/436,421 (filed 2024-02-08) - This is the application number for US12185177B2 itself.
    • US20240187816A1 (published 2024-06-06) - An earlier publication of the current patent family.
    • US18/949,047 (filed 2024-11-15, published as US20250071507A1) - Another priority application listed in the family.

Projected Expiration Date:

For utility patents filed on or after June 8, 1995, the term generally ends twenty years from the filing date of the earliest application for which a benefit is claimed under 35 U.S.C. 120, 121, or 365(c).

  • Earliest Priority Date: October 12, 2007 (from U.S. patent application Ser. No. 11/974,258).
  • Calculated Expiration Date (without adjustments): October 12, 2007 + 20 years = October 12, 2027.

The "Legal status" section of the patent information also explicitly states "Anticipated expiration: 2027-10-12". This confirms the calculation based on the earliest priority date.

Therefore, the projected expiration date for US Patent 12185177 is October 12, 2027. This date would be subject to any Patent Term Adjustments (PTA) or Patent Term Extensions (PTE) if applicable, but the provided information does not detail any such adjustments.

Generated 5/21/2026, 1:31:16 PM